secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVENUE THERAPEUTICS, INC. (ATXI)
CIK:        0001644963
Form:       8-K
Filed at:   2024-11-29T23:59:59+00:00
Accession:  0001104659-24-124081
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Avenue Therapeutics receives Nasdaq delisting notice for equity deficiency; intends to request hearing
--------------------------------------------------------------------------------

- Stockholders' equity of $1.652M as of Sep 30, 2024, below Nasdaq's $2.5M minimum requirement.
- Delisting determined due to prior Panel Monitor; company ineligible for 180-day extension submission.
- Trading continues; company must request hearing by Dec 3, 2024, to stay delisting.
- Company believes equity compliance regained per Q3 10-Q Note 9; will demonstrate at hearing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1644963/000110465924124081/0001104659-24-124081-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1644963/000110465924124081/tm2429840d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-124081

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer